NDC Compounded Drug 73702-117-03 Norepinephrine
Injection Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Norepinephrine
NDC crossover of Norepinephrine Bitartrate with NDC 73702-117 a human compounded drug with other similar products matching the same substance name (Norepinephrine) and the same administration route (intravenous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
73702-114-03 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | 250 mL in 1 BAG | Injection | Intravenous | Wells Pharma Of Houston |
73702-115-03 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | 250 mL in 1 BAG | Injection | Intravenous | Wells Pharma Of Houston |
73702-116-03 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | 250 mL in 1 BAG | Injection | Intravenous | Wells Pharma Of Houston |
73702-118-03 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | 250 mL in 1 BAG | Injection | Intravenous | Wells Pharma Of Houston |
73702-119-03 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | 250 mL in 1 BAG | Injection | Intravenous | Wells Pharma Of Houston |
Frequently Asked Questions
What is the NDC number assigned to Norepinephrine Bitartrate?
Norepinephrine Bitartrate was assigned by its manufacturer with NDC product code 73702-117. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Norepinephrine Bitartrate?
The NDC package code 73702-117-03 was assigned to a 250 mL in 1 BAG of norepinephrine administered intravenous via injection.
Who manufactures this product?
Norepinephrine Bitartrate is manufactured by an outsourced facility and labeled by Wells Pharma Of Houston. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 5 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Wells Pharma of Houston with NDC product codes 73702-114-03, 73702-115-03, 73702-116-03, 73702-118-03 and 73702-119-03.